These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19890890)

  • 1. Wnts, bone and cancer.
    Thomas DM
    J Pathol; 2010 Jan; 220(1):1-4. PubMed ID: 19890890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
    Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
    J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the interactions between the adhesive and transcriptional functions of beta-catenin in normal and cancerous cells.
    van Leeuwen IM; Byrne HM; Jensen OE; King JR
    J Theor Biol; 2007 Jul; 247(1):77-102. PubMed ID: 17382967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signalling and the mechanistic basis of tumour development.
    Ilyas M
    J Pathol; 2005 Jan; 205(2):130-44. PubMed ID: 15641015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists.
    Chan A; van Bezooijen RL; Löwik CW
    Curr Opin Investig Drugs; 2007 Apr; 8(4):293-8. PubMed ID: 17458178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
    Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When prostate cancer meets bone: control by wnts.
    Emami KH; Corey E
    Cancer Lett; 2007 Aug; 253(2):170-9. PubMed ID: 17462819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gust of WNT: analysis of the canonical WNT pathway.
    Giunta S
    Acta Biomed; 2009; 80(3):187-99. PubMed ID: 20578410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
    Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
    Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt and calcium signaling: beta-catenin-independent pathways.
    Kohn AD; Moon RT
    Cell Calcium; 2005; 38(3-4):439-46. PubMed ID: 16099039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells.
    Olkku A; Mahonen A
    Bone; 2009 Apr; 44(4):555-65. PubMed ID: 19100874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin.
    Brembeck FH; Rosário M; Birchmeier W
    Curr Opin Genet Dev; 2006 Feb; 16(1):51-9. PubMed ID: 16377174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signalling and prostate cancer.
    Yardy GW; Brewster SF
    Prostate Cancer Prostatic Dis; 2005; 8(2):119-26. PubMed ID: 15809669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
    Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
    Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling in the intestinal epithelium: from endoderm to cancer.
    Gregorieff A; Clevers H
    Genes Dev; 2005 Apr; 19(8):877-90. PubMed ID: 15833914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.
    Martinez G; Wijesinghe M; Turner K; Abud HE; Taketo MM; Noda T; Robinson ML; de Iongh RU
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4794-806. PubMed ID: 19515997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wnt/beta-catenin signaling pathway and drug discovery].
    Takahashi-Yanaga F; Sasaguri T
    Fukuoka Igaku Zasshi; 2007 Apr; 98(4):93-9. PubMed ID: 17533982
    [No Abstract]   [Full Text] [Related]  

  • 20. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.